CS239929B2 - Processing of pyridazine derivatives - Google Patents

Processing of pyridazine derivatives Download PDF

Info

Publication number
CS239929B2
CS239929B2 CS825913A CS591382A CS239929B2 CS 239929 B2 CS239929 B2 CS 239929B2 CS 825913 A CS825913 A CS 825913A CS 591382 A CS591382 A CS 591382A CS 239929 B2 CS239929 B2 CS 239929B2
Authority
CS
Czechoslovakia
Prior art keywords
group
formula
hydrogen
solvent
methyl
Prior art date
Application number
CS825913A
Other languages
Czech (cs)
English (en)
Inventor
Camille G Wermuth
Jean-Pierre Chambon
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of CS239929B2 publication Critical patent/CS239929B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/34Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CS825913A 1981-08-11 1982-08-09 Processing of pyridazine derivatives CS239929B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8115546A FR2511366A1 (fr) 1981-08-11 1981-08-11 Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent

Publications (1)

Publication Number Publication Date
CS239929B2 true CS239929B2 (en) 1986-01-16

Family

ID=9261385

Family Applications (1)

Application Number Title Priority Date Filing Date
CS825913A CS239929B2 (en) 1981-08-11 1982-08-09 Processing of pyridazine derivatives

Country Status (30)

Country Link
US (1) US4710499A (US20020095090A1-20020718-M00002.png)
EP (1) EP0073161B1 (US20020095090A1-20020718-M00002.png)
JP (1) JPS5838263A (US20020095090A1-20020718-M00002.png)
KR (1) KR880002711B1 (US20020095090A1-20020718-M00002.png)
AR (1) AR231537A1 (US20020095090A1-20020718-M00002.png)
AT (1) ATE23042T1 (US20020095090A1-20020718-M00002.png)
AU (1) AU579570B2 (US20020095090A1-20020718-M00002.png)
CA (1) CA1179347A (US20020095090A1-20020718-M00002.png)
CS (1) CS239929B2 (US20020095090A1-20020718-M00002.png)
DD (1) DD202550A5 (US20020095090A1-20020718-M00002.png)
DE (1) DE3273893D1 (US20020095090A1-20020718-M00002.png)
DK (1) DK148596C (US20020095090A1-20020718-M00002.png)
EG (1) EG15749A (US20020095090A1-20020718-M00002.png)
ES (1) ES8305736A1 (US20020095090A1-20020718-M00002.png)
FI (1) FI72970C (US20020095090A1-20020718-M00002.png)
FR (1) FR2511366A1 (US20020095090A1-20020718-M00002.png)
GR (1) GR76236B (US20020095090A1-20020718-M00002.png)
HU (1) HU189608B (US20020095090A1-20020718-M00002.png)
IE (1) IE53493B1 (US20020095090A1-20020718-M00002.png)
IL (1) IL66424A (US20020095090A1-20020718-M00002.png)
MA (1) MA19559A1 (US20020095090A1-20020718-M00002.png)
NO (1) NO158871C (US20020095090A1-20020718-M00002.png)
NZ (1) NZ201553A (US20020095090A1-20020718-M00002.png)
OA (1) OA07179A (US20020095090A1-20020718-M00002.png)
PH (1) PH18921A (US20020095090A1-20020718-M00002.png)
PL (1) PL137200B1 (US20020095090A1-20020718-M00002.png)
PT (1) PT75372B (US20020095090A1-20020718-M00002.png)
SU (1) SU1356960A3 (US20020095090A1-20020718-M00002.png)
YU (1) YU171682A (US20020095090A1-20020718-M00002.png)
ZA (1) ZA825515B (US20020095090A1-20020718-M00002.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539741A1 (fr) * 1983-01-21 1984-07-27 Sanofi Sa Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
JPS60218377A (ja) * 1984-04-16 1985-11-01 Mitsubishi Yuka Yakuhin Kk 4−フエニルフタラジン誘導体及びそれを有効成分とする循環改善剤
EP0190563B1 (de) * 1985-01-14 1989-08-02 Boehringer Ingelheim Kg Neue 12-Amino-pyridazino[4',5':3,4]pyrrolo-[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
ES2114654T3 (es) 1993-06-08 1998-06-01 Vertex Pharma Piridazinas como inhibidores de la enzima de conversion de la interleuquina-1beta.
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
GB9707693D0 (en) * 1997-04-16 1997-06-04 Smithkline Beecham Plc Novel method of treatment
EP2264014A1 (en) * 2001-08-31 2010-12-22 Université Louis Pasteur Substituted pyridazines as anti-inflammatory agents and protein kinase inhibitors
EP1812007B1 (en) * 2004-11-02 2011-09-07 Northwestern University Pyridazine compounds and methods
BRPI0517947A (pt) * 2004-11-02 2008-10-21 Univ Northwestern composto de piridazina, composições e métodos
EP2015751A2 (en) * 2006-04-28 2009-01-21 Northwestern University Salts of pyridazine compounds
JP2009535344A (ja) * 2006-04-28 2009-10-01 ノースウェスタン ユニバーシティ 神経炎症性疾患の処置のためのピリダジン化合物を含む処方物
CA2650711A1 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
AU2008223066A1 (en) * 2007-03-02 2008-09-12 Northwestern University Compositions comprising derivatives of 3 -phenylpyridazine for treating seizure-related disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives
FR2473522A1 (fr) * 1980-01-16 1981-07-17 Synthelabo Nouveaux derives substitues de dihydro-2,3 imidazo(1,2-b)pyridazines et les medicaments, utiles notamment comme antidepresseurs, qui en contiennent

Also Published As

Publication number Publication date
AU579570B2 (en) 1988-12-01
FR2511366B1 (US20020095090A1-20020718-M00002.png) 1984-12-14
PL137200B1 (en) 1986-05-31
DD202550A5 (de) 1983-09-21
JPS5838263A (ja) 1983-03-05
FI822768A0 (fi) 1982-08-09
US4710499A (en) 1987-12-01
DK148596C (da) 1986-01-13
NO158871B (no) 1988-08-01
NO158871C (no) 1988-11-09
FI822768L (fi) 1983-02-11
NZ201553A (en) 1985-08-16
YU171682A (en) 1985-03-20
KR840001147A (ko) 1984-03-28
NO822717L (no) 1983-02-14
ES514887A0 (es) 1983-04-16
DK148596B (da) 1985-08-12
HU189608B (en) 1986-07-28
DE3273893D1 (en) 1986-11-27
PT75372A (en) 1982-09-01
PL237836A1 (en) 1983-02-28
AU8702982A (en) 1983-05-12
EG15749A (en) 1986-09-30
IL66424A (en) 1985-10-31
FI72970C (fi) 1987-08-10
ZA825515B (en) 1983-06-29
OA07179A (fr) 1984-04-30
IE53493B1 (en) 1988-11-23
ES8305736A1 (es) 1983-04-16
FR2511366A1 (fr) 1983-02-18
ATE23042T1 (de) 1986-11-15
DK358782A (da) 1983-02-12
EP0073161A1 (fr) 1983-03-02
SU1356960A3 (ru) 1987-11-30
KR880002711B1 (ko) 1988-12-26
PT75372B (en) 1984-12-10
PH18921A (en) 1985-11-11
EP0073161B1 (fr) 1986-10-22
AR231537A1 (es) 1984-12-28
MA19559A1 (fr) 1983-04-01
GR76236B (US20020095090A1-20020718-M00002.png) 1984-08-04
FI72970B (fi) 1987-04-30
IE821822L (en) 1983-02-11
IL66424A0 (en) 1982-11-30
JPH0456032B2 (US20020095090A1-20020718-M00002.png) 1992-09-07
CA1179347A (en) 1984-12-11

Similar Documents

Publication Publication Date Title
CS239929B2 (en) Processing of pyridazine derivatives
US3995039A (en) Pyrazolo [1,5-a] [1,3,5] triazines
JPS6089474A (ja) モルフイナン誘導体,その製造方法,及び該化合物を含有する抗腫瘍剤
EP0047536B1 (en) Substituted propylamines
FR2619818A1 (fr) Imidazo (1,2-b) pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant
CH662563A5 (fr) Derives de coumarine, leurs procedes de preparation et compositions pharmaceutiques les contenant.
EP0172058A1 (fr) Nouvelles phényl-naphthyridines, leur procédé de préparation, médicaments les contenant, notamment anti-ulcères
CN111233820B (zh) 含有冠醚和二(2-甲氧基乙氧基)结构的芬戈莫德衍生物
PL77035B1 (US20020095090A1-20020718-M00002.png)
US4927821A (en) Enol ethers of 6-chloro-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide, and their use
GB2193210A (en) Glycine derivatives
EP0032856B1 (fr) Nouveaux dérivés de dihydro-2,3-imidazo(1,2-b)pyridazines, leur procédé de préparation et leur application en thérapeutique
RU2075477C1 (ru) 1-//2-(динизший алкиламино)алкил/амино/-4-замещенные тиоксантен-9-оны и фармацевтическая композиция, обладающая противоопухолевой активностью
CZ321095A3 (en) Heterocyclic compounds
US4143143A (en) Substituted imidazo[5,1-a]isoquinolines
JPS6197274A (ja) 中枢神経系に作用するチアジアゾール誘導体、その製造方法及びこの薬理上許容し得る塩
EP0058009A1 (en) Novel benzanilide derivatives and pharmaceutical compositions containing them
US4241053A (en) Novel nitrosourea compounds and process for preparing the same
EP0204172B1 (en) Phenylpyrazine derivatives, processes for preparing them, pharmaceutical composition and use
JPS62108863A (ja) 2−ピリジル酢酸誘導体、その製法およびそれを含む医薬
RU2068415C1 (ru) 5,7-диокси-2-метил-8-/4-(3-окси-1-(1-пропил)пиперидинил/-4н-1-бензопиран-4-он или его стереоизомеры или фармакологически приемлемые кислотно-аддитивные соли и способ их получения
KR860001862B1 (ko) 디알카노일옥시벤질리덴 디알카노에이트의 제조방법
FR2487351A1 (US20020095090A1-20020718-M00002.png)
KR800001132B1 (ko) 복소환 치환기를 가진 5-설파모일벤조산 유도체의 제조방법
FR2539739A1 (fr) Nouveaux derives de la naphtyl pyridazine actifs sur le systeme nerveux central, procede de preparation de ces derives et medicaments en contenant